Clinical Validation of a Urine Test (Uromonitor-V2®) for the Surveillance of Non-Muscle-Invasive Bladder Cancer Patients

European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update

(2019) Marko Babjuk et al.   EUROPEAN UROLOGY

Validation of a Novel, Sensitive, and Specific Urine-Based Test for Recurrence Surveillance of Patients With Non-Muscle-Invasive Bladder Cancer in a Comprehensive Multicenter Study

(2019) Rui Batista et al.   Frontiers in Genetics

An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer

(2018) Francesco Soria et al.   WORLD JOURNAL OF UROLOGY

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Prospective Validation of an mRNA-based Urine Test for Surveillance of Patients with Bladder Cancer

(2018) F. Johannes P. van Valenberg et al.   EUROPEAN UROLOGY

Performance Characteristics of a Multigene Urine Biomarker Test for Monitoring for Recurrent Urothelial Carcinoma in a Multicenter Study

(2017) Laimonis Kavalieris et al.   JOURNAL OF UROLOGY

Comparative Effectiveness of Fluorescent Versus White Light Cystoscopy for Initial Diagnosis or Surveillance of Bladder Cancer on Clinical Outcomes: Systematic Review and Meta-Analysis

(2017) Roger Chou et al.   JOURNAL OF UROLOGY

Economic Burden of Bladder Cancer Across the European Union

(2016) Jose Leal et al.   EUROPEAN UROLOGY

The Clinical Research Office of the Endourological Society (CROES) Multicentre Randomised Trial of Narrow Band Imaging–Assisted Transurethral Resection of Bladder Tumour (TURBT) Versus Conventional White Light Imaging–Assisted TURBT in Primary Non–Muscle-invasive Bladder Cancer Patients: Trial Protocol and 1-year Results

(2016) Seiji Naito et al.   EUROPEAN UROLOGY

EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non–Muscle-invasive Stage Ta–T1 Urothelial Bladder Cancer Patients Treated with 1–3 Years of Maintenance Bacillus Calmette-Guérin

(2016) Samantha Cambier et al.   EUROPEAN UROLOGY

Urinary Biomarkers for Diagnosis of Bladder Cancer

(2015) Roger Chou et al.   ANNALS OF INTERNAL MEDICINE

Adequacy in voided urine cytology specimens: The role of volume and a repeat void upon predictive values for high-grade urothelial carcinoma

(2015) Christopher J. VandenBussche et al.   CANCER CYTOPATHOLOGY

Prognostic Factors and Risk Groups in T1G3 Non–Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients

(2015) Paolo Gontero et al.   EUROPEAN UROLOGY

Mutations inTERTpromoter andFGFR3and telomere length in bladder cancer

(2015) Ismail Hosen et al.   INTERNATIONAL JOURNAL OF CANCER

Improving Selection Criteria for Early Cystectomy in High-Grade T1 Bladder Cancer: A Meta-Analysis of 15,215 Patients

(2015) William Martin-Doyle et al.   JOURNAL OF CLINICAL ONCOLOGY

Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer

(2015) Faysal A. Yafi et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Photodynamic Diagnosis of Non–muscle-invasive Bladder Cancer with Hexaminolevulinate Cystoscopy: A Meta-analysis of Detection and Recurrence Based on Raw Data

(2013) Maximilian Burger et al.   EUROPEAN UROLOGY

Telomerase Reverse Transcriptase Promoter Mutations in Bladder Cancer: High Frequency Across Stages, Detection in Urine, and Lack of Association with Outcome

(2013) Yves Allory et al.   EUROPEAN UROLOGY

Comprehensive Mutation Analysis of the TERT Promoter in Bladder Cancer and Detection of Mutations in Voided Urine

(2013) Carolyn D. Hurst et al.   EUROPEAN UROLOGY

TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism

(2013) P. S. Rachakonda et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Epidemiology and Risk Factors of Urothelial Bladder Cancer

(2012) Maximilian Burger et al.   EUROPEAN UROLOGY

The EORTC Tables Overestimate the Risk of Recurrence and Progression in Patients with Non–Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: External Validation of the EORTC Risk Tables

(2011) Jesus Fernandez-Gomez et al.   EUROPEAN UROLOGY

Oncogenic role of fibroblast growth factor receptor 3 in tumorigenesis of urinary bladder cancer

(2010) Arshad A. Pandith et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS